GL1X · GenesisL1 explorer

MolNFT v1 · #80498 · protein

Sar development and discovery of potent indole-based inhibitors of the hepatitis C virus NS5B polymerase

3TYQ · RNA-directed RNA polymerase: “Sar development and discovery of potent indole-based inhibitors of the hepatitis C virus NS5B polymerase”. X-ray diffraction, 2 ligands (HI4, PO4), 16 pockets (best druggability 0.80). MolNFT v1 #80498…

PDB
3TYQ
Type
protein
Length
1,121 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
RNA-directed RNA polymerase
EC
2.7.7.48
UniProt
O92972
Ligands
HI4, PO4
Pockets
16 · best druggability 0.80

Structure

x-ray diffraction · 2 distinct chains · 49% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ARNA-directed RNA polymerase (EC 2.7.7.48)protein56349% helix, 15% strandO92972
BRNA-directed RNA polymerase (EC 2.7.7.48)protein55849% helix, 15% strandO92972

Ligands and binding sites

  • HI4 · 5-ethyl-1-(2-fluoro-5-nitrobenzyl)-3-(2-oxo-1,2-dihydropyridin-3-yl)-1H-indole-2-carboxylic acid · ligand · 2 copies · chains A, B
  • PO4 · Phosphate ion · ion · 3 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

16 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111010.800.8291HI4
210760.800.8191HI4
3980.500.8219empty
41260.490.8019empty
51170.440.7823empty

Interfaces

1 interface between chains.

  • A–B · 997 Ų buried · 14 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 covalent (covalent ligand).

Compared structures

  • 3TYQ · SAR development and discovery of potent indole-based inhibitors of the hepatitis c virus… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.